Hormones lead to cancer treatment breakthrough
Source: Alfred Health, August 2022
Biological differences between men and women can have an impact on the success of melanoma treatment, according to new research co-led by Alfred oncologist Miles Andrews.
The study has shown that using medication to block a naturally occurring hormone in melanoma patients undergoing targeted cancer treatment may hold the key to better outcomes.
Dr Andrews said that inhibiting the hormone testosterone – which is commonly found at higher levels in the male body – can significantly increase melanoma cells’ sensitivity and help the body push past treatment resistance.